Breakdown | |||||
TTM | Mar 2024 | Mar 2023 | Mar 2022 | Mar 2021 | Mar 2020 |
---|---|---|---|---|---|
Income Statement | Total Revenue | ||||
27.07B | 28.83B | 32.86B | 29.40B | 22.36B | 26.14B | Gross Profit |
5.47B | 5.61B | 6.14B | 4.88B | 3.34B | 3.82B | EBIT |
2.25B | 2.31B | 2.83B | 1.56B | 119.00M | -97.00M | EBITDA |
3.06B | 3.36B | 3.79B | 2.66B | 1.16B | 1.13B | Net Income Common Stockholders |
1.52B | 1.49B | 2.06B | 1.33B | -208.00M | -500.00M |
Balance Sheet | Cash, Cash Equivalents and Short-Term Investments | ||||
1.59B | 1.99B | 1.20B | 2.15B | 2.52B | 1.94B | Total Assets |
19.52B | 19.70B | 20.63B | 22.34B | 20.32B | 20.64B | Total Debt |
4.17B | 5.41B | 7.68B | 10.60B | 11.93B | 11.65B | Net Debt |
2.58B | 3.41B | 6.48B | 8.45B | 9.41B | 10.17B | Total Liabilities |
10.42B | 11.77B | 14.65B | 18.24B | 17.85B | 18.12B | Stockholders Equity |
8.98B | 7.84B | 5.90B | 3.94B | 2.32B | 2.35B |
Cash Flow | Free Cash Flow | ||||
0.00 | 2.89B | 2.69B | 1.66B | 29.00M | 80.00M | Operating Cash Flow |
0.00 | 3.17B | 3.14B | 2.52B | 1.28B | 1.30B | Investing Cash Flow |
0.00 | 6.00M | -430.00M | -620.00M | -1.12B | -1.32B | Financing Cash Flow |
0.00 | -2.36B | -3.80B | -2.37B | 474.00M | -335.00M |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
---|---|---|---|---|---|---|---|
77 Outperform | ¥8.55B | 4.11 | 5.30% | 1.75% | 29.94% | ||
61 Neutral | $11.55B | 10.41 | -6.86% | 2.93% | 7.50% | -8.30% | |
€57.19M | 5.22 | -15.14% | 3.08% | ― | ― | ||
79 Outperform | ¥9.20B | 12.39 | 2.69% | 0.69% | -25.68% | ||
74 Outperform | ¥9.40B | 20.39 | 5.04% | 6.48% | 277.27% | ||
73 Outperform | ¥9.50B | 21.07 | 2.37% | -3.36% | 39.15% | ||
72 Outperform | ¥9.60B | 23.91 | 6.06% | -2.94% | -52.90% |